Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management
Digital Health Global
JUNE 6, 2023
Then, physicians can determine if a prescription was filled and have the option to develop a personalized care plan based on the data provided. “As Contacts Media Contact Katie Beach Evoke Canale for Phil Katherine.Beach@canalecomm.com PR Contacts Teva Pharmaceuticals Kelley Dougherty, (973) 832-2810 Yonatan Beker, (973) 264-7378
Let's personalize your content